Carvedilol Inhibits Mitochondrial Oxygen Consumption and Superoxide Production During Calcium Overload in Isolated Heart Mitochondria

概要

論文の詳細を見る
Background The COMET study suggested the better effect of carvedilol to metoprolol in treating heart failure. However, its underlying mechanisms of action remain unclear. As a result, evaluation of the distinct effects of both drugs on the mitochondrial function and reactive oxygen species (ROS) production during Ca^<2+> overload was investigated. Methods and Results The mitochondrial oxygen consumption (mVO_2) and the mitochondrial ROS production in isolated rat heart mitochondria was measured. Ca^<2+> overload from 10 to 100μmol/L augmented mVO_2 was from 527±139 to 671±138 nmol/mg (p<0.05), and this was then completely suppressed by carvedilol (1μmol/L), but not by metoprolol (100μmol/L). Ca^<2+> overload augmented the ROS production upon complex I injury (9.7±1.2 to 11.4±1.4 nmol/mg, p<0.05). Carvedilol dose-dependently suppressed this ROS production, whereas metoprolol did not. Conclusions Carvedilol, but not metoprolol, was thus found to inhibit the calcium-dependent augmentation of mVO_2 and ROS production upon complex I injury. This new effect of carvedilol might partly explain the beneficial effect of carvedilol for the treatment of heart failure.
社団法人日本循環器学会の論文
2006-02-20